Concerning the quantification of EVs in patients, we observed a significantly higher increase in CD45+ (p = 0.035) and a trend towards higher increase in CD146+ (p = 0.059) in patients with CTEPH compared with patients who had only presented PE. Here, PTPRC is linked to chronic thromboembolic pulmonary hypertension.